Overview

Peyronie's Disease Treatment Protocol

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

Treatment of Peyronie's disease remains difficult. The purpose of this study is to test the safety and efficacy of a new compound to treat this disease.

Phase:

Phase 1

Details

Lead Sponsor:

Hybrid Medical